Filing Details
- Accession Number:
- 0001104659-11-044895
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-08 16:47:24
- Reporting Period:
- 2011-08-05
- Filing Date:
- 2011-08-08
- Accepted Time:
- 2011-08-08 16:47:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887359 | Aastrom Biosciences Inc | ASTM | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1242613 | M Timothy Mayleben | C/O Aastrom Biosciences, Inc. P.o. Box 376 Ann Arbor MI 48106 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-05 | 20,000 | $2.36 | 123,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.31 to $2.40, inclusive. The reporting person undertakes to provide to Aastrom Biosciences, Inc., any security holder of Aastrom Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.